Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,339 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
[Cytogentic and prognostic characteristic of acute myeloid leukemia with monosomal karyotype].
Li Z, Wei H, Lin D, Zhou CL, Liu BC, Wang Y, Liu KQ, Li W, Gong BF, Wei SN, Zhang GJ, Zhao XL, Li Y, Liu YT, Gong XY, Gu RX, Qiu SW, Mi YC, Wang JX. Li Z, et al. Among authors: liu bc, liu kq, liu yt. Zhonghua Xue Ye Xue Za Zhi. 2016 May 14;37(5):366-71. doi: 10.3760/cma.j.issn.0253-2727.2016.05.003. Zhonghua Xue Ye Xue Za Zhi. 2016. PMID: 27210869 Free PMC article. Chinese.
[A single-center, randomized controlled trial of PEG-rhG-CSF and common rhG-CSF to promote neutrophil recovery after induction chemotherapy in newly diagnosed acute myeloid leukemia].
Liu KQ, Wang Y, Zhao Z, Lin D, Zhou CL, Liu BC, Gong XY, Zhao XL, Wei SN, Zhang GJ, Gong BF, Li Y, Liu YT, Mi YC, Wang JX, Wei H. Liu KQ, et al. Among authors: liu bc, liu yt. Zhonghua Xue Ye Xue Za Zhi. 2019 Jun 14;40(6):497-501. doi: 10.3760/cma.j.issn.0253-2727.2019.06.009. Zhonghua Xue Ye Xue Za Zhi. 2019. PMID: 31340623 Free PMC article. Clinical Trial. Chinese.
[Rituximab combined with short-course and intensive regimen for Burkitt leukemia: efficacy and safety analysis].
Li Y, Gong XY, Zhao XL, Wei H, Wang Y, Lin D, Zhou CL, Liu BC, Wang HJ, Li CW, Li QH, Gong BF, Liu YT, Wei SN, Zhang GJ, Mi YC, Wang JX, Liu KQ. Li Y, et al. Among authors: liu bc, liu kq, liu yt. Zhonghua Xue Ye Xue Za Zhi. 2020 Jun 14;41(6):502-505. doi: 10.3760/cma.j.issn.0253-2727.2020.06.012. Zhonghua Xue Ye Xue Za Zhi. 2020. PMID: 32654465 Free PMC article. Chinese.
[Dasatinib combined with multi-agent chemotherapy regimen in newly diagnosed Philadelphia chromosome-positive acute lymphoblastic leukemia: a prospective study from a single center].
Zhang GJ, Gong XY, Qiu SW, Zhou CL, Liu KQ, Lin D, Liu BC, Wei H, Wei SN, Li Y, Gu RX, Gong BF, Liu YT, Fang QY, Mi YC, Wang Y, Wang JX. Zhang GJ, et al. Among authors: liu bc, liu kq, liu yt. Zhonghua Xue Ye Xue Za Zhi. 2021 Feb 14;42(2):109-115. doi: 10.3760/cma.j.issn.0253-2727.2021.02.004. Zhonghua Xue Ye Xue Za Zhi. 2021. PMID: 33858040 Free PMC article. Chinese.
[The characteristics and prognostic impact of NOTCH1/FBXW7 mutation and CDKN2A/B deletion in adult T-cell acute lymphoblastic leukemia patients].
Fang QY, Hao QS, Gong XY, Wang J, Li QH, Yuan T, Tian Z, Liu KQ, Li Y, Liu YT, Gong BF, Wang Y, Wei H, Zhou CL, Lin D, Liu BC, Wei SN, Zhang GJ, Wang JX, Mi YC. Fang QY, et al. Among authors: liu bc, liu kq, liu yt. Zhonghua Xue Ye Xue Za Zhi. 2021 May 14;42(5):432-435. doi: 10.3760/cma.j.issn.0253-2727.2021.05.015. Zhonghua Xue Ye Xue Za Zhi. 2021. PMID: 34218589 Free PMC article. Chinese. No abstract available.
[Comparison of the efficacy of IA and HAD induction regimens in the treatment of patients with newly diagnosed acute myeloid leukemia: a single-center study].
Zhang CX, Qiu SW, Gong BF, Gong XY, Li Y, Liu YT, Fang QY, Zhang GJ, Liu KQ, Zhou CL, Wei SN, Lin D, Liu BC, Wang Y, Mi YC, Wei H, Wang JX. Zhang CX, et al. Among authors: liu bc, liu kq, liu yt. Zhonghua Xue Ye Xue Za Zhi. 2022 May 14;43(5):383-387. doi: 10.3760/cma.j.issn.0253-2727.2022.05.006. Zhonghua Xue Ye Xue Za Zhi. 2022. PMID: 35680595 Free PMC article. Chinese.
[Efficacy and safety of IAC regimen for relapse/refractory acute myeloid leukemia: a prospective randomized controlled study].
Li CH, Wei SN, Qiu SW, Gong BF, Gong XY, Li Y, Liu YT, Fang QY, Zhang GJ, Liu KQ, Zhou CL, Lin D, Liu BC, Wang Y, Mi YC, Wei H, Wang JX. Li CH, et al. Among authors: liu bc, liu kq, liu yt. Zhonghua Xue Ye Xue Za Zhi. 2022 Apr 14;43(4):287-292. doi: 10.3760/cma.j.issn.0253-2727.2022.04.004. Zhonghua Xue Ye Xue Za Zhi. 2022. PMID: 35680626 Free PMC article. Clinical Trial. Chinese.
[Homoharringtonine in newly diagnosed acute promyelocytic leukemia treatment: a prospective, randomized controlled trial].
Wang Y, Liu BC, Wei H, Lin D, Zhou CL, Liu KQ, Li W, Wei SN, Wang JY, Gong BF, Zhang GJ, Zhao XL, Liu YT, Gong XY, Li Y, Gu RX, Mi YC, Wang JX. Wang Y, et al. Among authors: liu bc, liu kq, liu yt. Zhonghua Xue Ye Xue Za Zhi. 2016 Mar;37(3):183-8. doi: 10.3760/cma.j.issn.0253-2727.2016.03.002. Zhonghua Xue Ye Xue Za Zhi. 2016. PMID: 27033753 Free PMC article. Clinical Trial. Chinese.
[The clinical and prognostic significance of acute myeloid leukemia with FLT3-ITD].
Lin D, Wei H, Wang Y, Zhou CL, Liu BC, Liu KQ, Gong BF, Wei SN, Zhang GJ, Liu YT, Gong XY, Qiu SW, Mi YC, Wang JX. Lin D, et al. Among authors: liu bc, liu kq, liu yt. Zhonghua Xue Ye Xue Za Zhi. 2016 Dec 14;37(12):1017-1021. doi: 10.3760/cma.j.issn.0253-2727.2016.12.001. Zhonghua Xue Ye Xue Za Zhi. 2016. PMID: 28088961 Free PMC article. Chinese.
1,339 results